Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-25 @ 7:04 PM
NCT ID:
NCT05278104
Pre Assignment Details:
63 male and female participants (32 atomoxetine, 31 placebo) were randomized and 62 participants were treated. Out of these, 58 completed the planned treatment and trial per protocol; 2 were erroneously randomized and discontinued (one treated and one not treated); 3 discontinued due to other reasons. All participants were free to withdraw at any time and were closely monitored.
Recruitment Details:
This was a multi-center, randomized, double-blind, placebo controlled parallel-group trial in participants with attention deficit hyperactivity disorder (ADHD). Eligible participants were randomized in a 1:1 ratio to receive either placebo or atomoxetine during a 2-week double-blind treatment period.
Study:
NCT05278104
Study Brief:
Results Section:
NCT05278104